900912.SS
900912.SS
CNE0000009V9
SHANGHAI WAIGAOQIAO FREE TRADE
Loading chart...
Solid Quality Asset with Moderate Fluctuation

Healthy balance: Exemplary business financials (Health Score: 67/100) paired with moderate price swings for a single equity (±17.2% p.a.). The score (5/7) reflects the standard baseline for equities under SRI rules.

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
5/7 Elevated
5 / 7 SRI Price Fluctuation & Beta

Above-average volatility. Suitable for experienced investors with high risk tolerance (5+ years horizon). Moves noticeably less than the broader market (0.2x).

Beta (Market Relation)
0.18x
Defensive
Volatility (5Y p.a.)
17.2% p.a.
5-Year Horizon
Max Drawdown (5Y)
-42.6%
5-Year Horizon
Sharpe Ratio
-0.54
Return / Risk
Elevated Risk / Growth: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -13.4%
3 Years 17.5% -27.0% -0.32 -3%
5 Years 17.2% -42.6% -0.54 -6.8%
10 Years 17.9% -65.6% -0.67 -9.5%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Strong cyclicality: The business model is sensitive to economic downturns.
Historical Stress Test: Maximum peak-to-trough drawdown of -65.6% in the extended horizon.
ende